Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease

被引:58
作者
Lv, Zhanyun [1 ,2 ]
Jiang, Hong [1 ,2 ]
Xu, Huamin [1 ,2 ]
Song, Ning [1 ,2 ]
Xie, Junxia [1 ,2 ]
机构
[1] Qingdao Univ, Coll Med, Dept Physiol, State Key Disciplines Physiol Incubat, Qingdao 266071, Peoples R China
[2] Qingdao Univ, Coll Med, Shandong Prov Key Lab Pathogenesis & Prevent Neur, Dept Physiol, Qingdao 266071, Peoples R China
关键词
Divalent metal transporter 1; Ferroportin; 1; Iron; A-synuclein; Parkinson's disease; METAL TRANSPORTER 1; SUBSTANTIA-NIGRA; ALPHA-SYNUCLEIN; IN-VITRO; INCLUSION-BODIES; OXIDATIVE STRESS; UP-REGULATION; MOUSE MODEL; CELL-DEATH; MPTP;
D O I
10.1007/s00702-010-0434-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The staging of Lewy-related pathology in sporadic Parkinson's disease (PD) reveals that many brain nuclei are affected in PD during different stages, except the ventral tegmental area (VTA), which is close related to the substantia nigra (SN) and enriched in dopamine (DA) neurons. Why DA neurons are selectively degenerated in the SN of PD is far from known. In the present study, we observed that the number of tyrosine hydroxylase immunoreactive neurons decreased and iron-staining positive cells increased in the SN, but not in the VTA, in the chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated PD mice. Increased expression of divalent metal transporter 1 and decreased expression of ferroportin 1 might associate with this increased nigral iron levels. Lipofuscin granular aggregations and upregulation of alpha-synuclein (alpha-synuclein) were also observed only in the SN. These results suggest that increased iron levels associate with the selective degeneration of DA neurons in the SN. The intracellular regulation mechanisms for the iron transporters may be different in the SN and VTA under the same conditions. Moreover, the lipofuscin granular aggregations and upregulation of alpha-synuclein were also involved in the selective degeneration of dopaminergic neurons in the SN.
引用
收藏
页码:361 / 369
页数:9
相关论文
共 50 条
[31]   Early Degeneration of Both Dopaminergic and Serotonergic Axons - A Common Mechanism in Parkinson's Disease [J].
Grosch, Janina ;
Winkler, Juergen ;
Kohl, Zacharias .
FRONTIERS IN CELLULAR NEUROSCIENCE, 2016, 10
[32]   Aminochrome as a preclinical experimental model to study degeneration of dopaminergic neurons in Parkinson's disease [J].
Paris, Irmgard ;
Cardenas, Sergio ;
Lozano, Jorge ;
Perez-Pastene, Carolina ;
Graumann, Rebecca ;
Riveros, Alejandra ;
Caviedes, Pablo ;
Segura-Aguilar, Juan .
NEUROTOXICITY RESEARCH, 2007, 12 (02) :125-134
[33]   Colour vision abnormalities do not correlate with dopaminergic nigrostriatal degeneration in Parkinson's disease [J].
Muller, T ;
Kuhn, W ;
Buttner, T ;
Eising, E ;
Coenen, H ;
Haas, M ;
Przuntek, H .
JOURNAL OF NEUROLOGY, 1998, 245 (10) :659-664
[34]   A novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP [J].
Son, Hyo Jin ;
Lee, Ji Ae ;
Shin, Nari ;
Choi, Ji Hyun ;
Seo, Jai Woong ;
Chi, Dae Yoon ;
Lee, Cheol Soon ;
Kim, Eun-Mee ;
Choe, Han ;
Hwang, Onyou .
BRITISH JOURNAL OF PHARMACOLOGY, 2012, 165 (07) :2213-2227
[35]   MicroRNA-26a/Death-Associated Protein Kinase 1 Signaling Induces Synucleinopathy and Dopaminergic Neuron Degeneration in Parkinson's Disease [J].
Su, Ying ;
Deng, Man-Fei ;
Xiong, Wan ;
Xie, Ao-Ji ;
Guo, Jifeng ;
Liang, Zhi-Hou ;
Hu, Bo ;
Chen, Jian-Guo ;
Zhu, Xiongwei ;
Man, Heng-Ye ;
Lu, Youming ;
Liu, Dan ;
Tang, Beisha ;
Zhu, Ling-Qiang .
BIOLOGICAL PSYCHIATRY, 2019, 85 (09) :769-781
[36]   SELF-AMPLIFICATION OF NIGRAL DEGENERATION IN PARKINSON'S DISEASE: A HYPOTHESIS [J].
Ionov, Ilya D. .
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2008, 118 (12) :1763-1780
[37]   Nigral diffusivity, but not free water, correlates with iron content in Parkinson's disease [J].
Langley, Jason ;
Huddleston, Daniel E. ;
Hu, Xiaoping .
BRAIN COMMUNICATIONS, 2021, 3 (04)
[38]   Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model [J].
Qi, Xin ;
Davis, Brandon ;
Chiang, Yung-Hsiao ;
Filichia, Emily ;
Barnett, Austin ;
Greig, Nigel H. ;
Hoffer, Barry ;
Luo, Yu .
JOURNAL OF NEUROCHEMISTRY, 2016, 138 (05) :746-757
[39]   Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease [J].
Jin, Lirong ;
Wang, Jian ;
Zhao, Lei ;
Jin, Hang ;
Fei, Guoqiang ;
Zhang, Yuwen ;
Zeng, Mengsu ;
Zhong, Chunjiu .
BRAIN, 2011, 134 :50-58
[40]   Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate [J].
Mortimer Mamelak .
Neurology and Therapy, 2018, 7 :5-11